Prudential Financial Inc. Sells 645,206 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Prudential Financial Inc. trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 61.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 404,014 shares of the pharmacy operator's stock after selling 645,206 shares during the period. Prudential Financial Inc.'s holdings in Walgreens Boots Alliance were worth $3,769,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock worth $805,506,000 after purchasing an additional 2,279,495 shares in the last quarter. State Street Corp raised its holdings in Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator's stock worth $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock worth $122,737,000 after buying an additional 2,185,950 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator's stock valued at $68,046,000 after buying an additional 817,762 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in Walgreens Boots Alliance by 9.6% in the fourth quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator's stock valued at $50,684,000 after acquiring an additional 478,061 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

WBA has been the subject of several recent research reports. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research note on Monday, January 13th. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research report on Wednesday, January 15th. Finally, StockNews.com assumed coverage on Walgreens Boots Alliance in a research note on Thursday. They issued a "hold" rating for the company. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Stock Down 1.1 %

Shares of WBA traded down $0.12 during trading on Thursday, reaching $11.06. The company's stock had a trading volume of 22,718,139 shares, compared to its average volume of 20,802,564. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $19.48. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a market cap of $9.56 billion, a price-to-earnings ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a fifty day moving average of $10.79 and a two-hundred day moving average of $9.95.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.66 earnings per share. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.